Carbogen Amcis AG has acquired Creapharm Parenterals, a subsidiary of France-based Creapharm Group. Creapharm Parenterals (formerly MP5) is a CDMO specializing in liquid, semi-solid and injectable aseptic dosage forms. As part of this acquisition, Creapharm Parenterals has changed its name to Carbogen Amcis SAS. Financial terms were not disclosed.   Mark Griffiths, chief executive officer of Carbogen Amcis, commented, “This exciting transaction further strengthens Carbogen Amcis’ service offerin...